Conference
Osimertinib then chemotherapy in EGFR-mutated lung cancer with osimertinib third-line rechallenge (OCELOT).
Authors
Breadner DA; Vincent MD; Liu G; Rothenstein J; Menjak IB; Cheema PK; Juergens RA; Mithoowani H; Bains P; Wang Y
Volume
41
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
June 1, 2023
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
IL, Chicago
Conference start date
June 2, 2023
Conference end date
June 6, 2023
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X